Has Dr. Oz disclosed any financial ties to the makers of Iron Boost?

1. What Oz has disclosed about supplements: an explicit iHerb tie

Dr. Oz’s financial filings and reporting identify a formal financial interest tied to iHerb: an entity called iHerb Oz Partners L.L.C., created when he began pitching for the company in 2023; outlets report he has said he would retain that interest while pledging divestiture of some health stocks ^{[1] [2]}. Fortune and Public Citizen reporting add that Oz regularly promoted iHerb products on social media while acting as a paid adviser, and watchdogs flagged a lack of prominent disclosure of that advisory role in those posts ^{[4] [6]}.

2. Iron Boost specifically: available sources do not mention it

The sources provided do not mention the product name “Iron Boost” or any financial tie by Dr. Oz to makers of a product with that name; available sources do not mention Iron Boost (p1_s1–^[8]5). Because the provided reporting names iHerb and other supplement ties but not Iron Boost, any claim that Oz disclosed ties to Iron Boost is not supported by these documents ^{[1] [4]}.

3. His broader ethics commitments and planned divestitures

Reporting on Oz’s nomination to lead the Centers for Medicare & Medicaid Services notes an ethics agreement and filings indicating he will divest many health-related holdings within 90 days of confirmation and recuse from matters directly affecting firms he still holds until divestiture or waiver ^[2]. The New York Times and NPR coverage emphasize he would step away from numerous holdings but retain or treat some interests (like iHerb entity mentions) in specific ways described in filings ^{[1] [2]}.

4. Where watchdogs and lawmakers see gaps or risks

Senator Elizabeth Warren and other Democrats pressed Oz to sever industry ties, citing deep financial connections to private insurers and other healthcare firms that CMS regulates; Reuters and Common Dreams summarize those concerns and demands for divestiture and recusal commitments ^{[5] [7]}. Public Citizen’s letter and Fortune reporting flagged his social-media endorsements of iHerb products without prominent disclosure of his paid advisory role, framing a transparency problem ^{[4] [6]}.

5. Conflicting perspectives in the record

News outlets report both Oz’s pledge to divest and recuse (NPR, New York Times) and warnings from ethics experts and lawmakers that his remaining or past ties could still create conflicts ^{[2] [1] [5]}. Some reporting frames his asset reduction as a corrective step; others emphasize the scale of his preexisting holdings (Sharecare, insurer and pharma stocks) and question whether divestiture timelines or passive-income arrangements fully mitigate conflicts ^{[3] [2]}.

6. What this means for someone asking about Iron Boost or similar products

For a single product-brand inquiry like “Iron Boost,” the current reporting does not identify Oz as having disclosed a tie to that maker; the publicly documented supplement relationship in these sources centers on iHerb and related advisory/partner entities ^{[1] [4]}. If you need confirmation about a specific product-maker, you should consult the maker’s disclosures, Oz’s most recent financial filings beyond those cited here, or direct statements from Oz’s office — none of which are present in the provided reporting (available sources do not mention the manufacturer of Iron Boost).

7. Limitations and next reporting steps

These conclusions rely solely on the supplied articles and filings excerpts; they do not include any post-publication corrections, newer ethics filings, or direct statements released after the cited pieces. If you want definitive confirmation about Iron Boost ties, request the latest financial disclosure forms, the iHerb (or maker’s) SEC/press statements, or targeted reporting that names Iron Boost explicitly — those documents would either confirm a tie or demonstrate its absence beyond the current coverage (available sources do not mention Iron Boost) ^{[2] [1] [4]}.